## Executive Summary LumaBio holds a strong legal position but faces significant procedural hurdles regarding damage caps and acceptance standards. The strongest leverage points are the evidence supporting a fraud claim (the pre-contract email coupled with internal engineering chats) and PrecisionFill’s negligent destruction of telemetry data (spoliation). However, PrecisionFill has credible defenses regarding LumaBio's failure to meet humidity specifications during testing and the use of non-compliant film. While litigation is viable due to the potential fraud exception to damage caps, the cost, time, and uncertainty of proving intent make a negotiated commercial resolution preferable. LumaBio should leverage the risk of sanctions (spoliation) and the threat of an uncapped fraud lawsuit to demand full performance (software fixes) plus monetary credits for past downtime, rather than paying the final $900,000 without resolution. --- ## Detailed Legal Analysis ### 1. Express Warranty and Breach PrecisionFill likely breached the express warranty regarding "Rated throughput: 300 vials per minute." * **Warranty Creation:** Under Rule 1, a factual affirmation ("Rated throughput") becomes an express warranty if it is part of the basis of the bargain. The specification of 300 vials/min is specific and measurable, not merely general praise. * **The Discrepancy:** While LumaBio met the *Site Acceptance* criteria (285 avg for 4 hours), the contract warranted a *Rated Throughput* of 300. Post-repair performance averages only 286–289 vials per minute, occasionally reaching 300 but not sustaining it. The machine fails to meet the "Rated" specification promised in the written agreement. * **Conclusion:** This constitutes a breach of warranty regarding the performance specifications, distinct from the Site Acceptance criteria which was merely a gateway for payment/installment release. ### 2. Admissibility and Fraud Claim (Pre-Contract Email) The VP's email is likely admissible as evidence of fraud, despite the merger clause. * **Merger Clause Limits:** Rule 3 states that while a merger clause excludes prior agreements, it does not automatically defeat a fraud claim based on an intentionally false factual representation known to the speaker. * **Fraud Elements (Rule 10):** * *False Statement:* "This line will run 300 all day... If it cannot, we will take it back." * *Scienter:* Internal chats show engineers knew the machine "probably tops out around 288" and explicitly instructed sales not to put that in writing. This establishes reckless disregard or knowledge of falsity. * *Reliance:* LumaBio signed based on the promise, noting internally they wanted to add the commitment but were pushed to sign anyway. * **Admissibility:** The email is not used to contradict the written contract (which would be barred by Rule 2) but to prove an independent tort (fraud) that voids liability limitations. ### 3. Acceptance Standards and Subsequent Conduct * **Site Acceptance:** LumaBio signed a certificate stating acceptance was completed. However, it noted "subject to sustained production validation." Since this criteria were undefined, the acceptance is arguably conditional on continued performance. * **The 285 Standard:** The line met the 285/4-hour test (averaged 287). PrecisionFill will argue the line was accepted as compliant. * **Subsequent Conduct:** Continued operation at 39–43% humidity post-repair yielded only 270 vials/min. This confirms a defect existed that was not apparent during the brief acceptance test (Rule 4). LumaBio cannot be deemed to have definitively accepted *conformity* when it reserved rights for "sustained production." ### 4. Right to Reject or Revoke Acceptance Revocation is legally difficult but theoretically possible. * **Revocation Requirements (Rule 4):** Revocation requires a nonconformity that substantially impairs value and must occur within a reasonable time before a substantial change not caused by the defect. * **Continued Use (Rule 5):** LumaBio used the line for eight months. This usually undermines revocation, though limited use to avoid serious loss is permitted. Since this was production equipment, continued use suggests reliance on its partial utility. * **Strategy:** Formal "revocation" is risky due to the 8-month delay and continued production. It is stronger to treat the machine as accepted but in *breach of warranty*, seeking damages/cure rather than returning the goods. ### 5. Timeliness of Notice LumaBio's formal breach notice was timely under the circumstances. * **Seller Knowledge (Rule 6):** While the formal notice was sent 75 days after sustained production began, PrecisionFill technicians had been working on the issues since week 1. Rule 6 states actual seller knowledge may affect whether formal notice was sufficient. LumaBio put them on constructive notice of "all contractual remedies" via email on Day 25. ### 6. Failure of Exclusive Remedy The exclusive remedy (Repair/Replace) likely failed its essential purpose. * **Ineffective Cure (Rule 7):** PrecisionFill took six weeks to deliver a patch. Even after the patch, the line does not sustain 300 vials/min, violating the Rated Throughput warranty. If the seller cannot or will not provide an effective cure within a reasonable time, the exclusive remedy fails. * **Consequential Damages:** Rule 7 states that even if the exclusive remedy fails, the exclusion of consequential damages usually remains enforceable *unless* it is unconscionable or expressly dependent on the remedy. The contract explicitly states the exclusion applies even if the remedy fails. This severely limits LumaBio's recovery for lost profits/customers unless Fraud is proven. ### 7. Recoverable Damages * **If Breach Only:** Damages are capped at the Purchase Price ($4.8M) (Contract). Consequential damages (lost customer order, lost profits) are barred. Direct damages (difference in value between 300 and actual output) and incidental damages (overtime, shipping) are recoverable. * **If Fraud Proven:** Rule 3 states liability limitations do not apply to fraud. This removes the $4.8M cap and allows recovery for lost customer orders/loss of production. * **Incidental Damages:** Overtime, temp labor, and expedited shipping are recoverable incidental damages if mitigated reasonably (Rule 8). ### 8. Withholding the Final Installment LumaBio is at risk regarding the withholding of the $900,000 installment. * **Deduction Rule (Rule 9):** A buyer may deduct damages from the price only after *notifying the seller of the intention* to do so. The facts state LumaBio "withheld" but do not confirm a specific notice calculating the set-off against the $900k. * **Risk:** PrecisionFill could argue LumaBio is in breach for non-payment despite the warranty dispute. However, given the magnitude of the defect and ongoing negotiations, withholding maintains leverage, provided they have notified of the intent to offset damages generally. ### 9. Spoliation and Telemetry Data This is a significant procedural advantage for LumaBio. * **Duty to Preserve (Rule 11):** Litigation was reasonably anticipated when LumaBio emailed on Day 25 ("considering all remedies"). * **Breach:** PrecisionFill did not suspend automatic deletion and overwrote raw data on Day 30. While they kept summary reports, the loss of raw telemetry prevents independent verification of performance. * **Sanctions:** Rule 11 allows for an adverse inference requiring intent to deprive. Given the internal knowledge that the line was underperforming (engineer chat), LumaBio can argue PrecisionFill intended to hide data proving non-conformity. This supports sanctions or jury instructions allowing them to infer the deleted data showed the machine failed even more severely than claimed. ### 10. Strongest Defenses for PrecisionFill * **Film Variance:** 18% of film lots were non-compliant with Schedule B. LumaBio had internal QC data showing this but did not disclose it. PrecisionFill can argue the machine's performance is tied to input quality; thus, LumaBio failed to provide the "basis of the bargain" inputs. * **Humidity:** During the initial failure period (238-260 vials/min), humidity was 52–60%, well outside the 35–45% spec. This performance was due to LumaBio’s HVAC project, not the machine. * **Merger/No Reliance:** The contract states LumaBio did not rely on statements not in the writing. This is a strong barrier against the "300 all day" email *as a warranty*, though less effective against fraud. --- ## Strategic Recommendation **Decision: Negotiate Commercial Settlement.** ### Rationale 1. **Litigation Risk:** While the fraud claim uncaps damages, proving intent and causation for lost profits in court is difficult and expensive. PrecisionFill will litigate aggressively to enforce the damage caps and blame film/humidity issues. 2. **Spoliation Leverage:** The overwritten telemetry is a "sword." It creates high risk for PrecisionFill regarding sanctions or credibility loss with a jury. This should not be used merely to win a case but to force leverage in negotiation. 3. **Operational Reality:** The line operates at 286–289 vials/min. While below the rated 300, it exceeds the *contractual acceptance* standard of 285 (averaged). LumaBio is likely to lose if the court deems the "Rated Throughput" as aspirational marketing vs. a warranty. 4. **Financial Impact:** Withholding the $900k damages LumaBio's credibility and could lead to PrecisionFill suing for specific performance/payment. ### Recommended Action Plan 1. **Do Not Pay Yet:** Maintain the $900,000 withholding as leverage but issue a formal "Notice of Intention to Deduct Damages" specifically referencing Rule 9 to mitigate the risk of a payment breach claim. 2. **Issue a Formal Demand Letter:** * Cite the failure to meet Rated Throughput (Warranty Breach). * Highlight the internal chat evidence regarding knowledge of performance limits (Fraud threat). * Demand immediate preservation of all remaining data (Spoliation warning). 3. **Negotiate Terms:** * **Goal:** Do not settle for a small credit. Seek: * Full engineering redesign to sustain 300 vials/min (or close, e.g., 295) at no cost. * A cash credit against the $900k installment equivalent to the documented downtime losses (overtime/shipping). * Waiver of liquidated damages if PrecisionFill fails the fix within 6 months. 4. **Prepare for Discovery:** If negotiation stalls, be ready to depose the engineers regarding the internal chat "Do not put 288 in writing." This evidence is likely dispositive on fraud intent. **Conclusion:** LumaBio should use the threat of an uncapped fraud lawsuit combined with spoliation sanctions to negotiate a deal that lowers the effective cost of the line and guarantees future performance, rather than paying the full amount or entering a long litigation where damage caps might survive if Fraud is not proven to a jury's satisfaction.